Navigation Links
Deloitte Chairman of the Board Sharon L. Allen Named Chairman of the American Friends of the Phelophepa Train
Date:11/16/2007

The AFPT organization is devoted to improving healthcare in rural South

Africa for the welfare of its people

NEW YORK, Nov. 16 /PRNewswire/ -- Sharon L. Allen, Chairman of the Board, Deloitte & Touche USA LLP, has been named Chairman of the Board of the American Friends of the Phelophepa Train (AFPT).

"It's an honor, on behalf of Deloitte, to support the critical work of the AFPT Board, Archbishop Desmond Tutu and Ms. Leah Tutu in bringing awareness to the healthcare needs of the people of South Africa to the United States," said Allen.

Allen, named Chairman of the Board of Deloitte in 2003 and re-elected Chairman in 2007, serves on the President's Export Council and is a member of the Women's Leadership Board of the JFK School of Government at Harvard University. Named one of Forbes' Magazines "Most Powerful Women in the World" for the past two years, she also serves on the national board of the YMCA, the Autry National Center of Los Angeles and the United Way of Greater Los Angeles.

Allen replaces James E. Copeland, Jr., former CEO of Deloitte and Deloitte Touche Tohmatsu, who has served as the Chairman of the AFPT organization for the past four years.

Founded in 1994, the Phelophepa (pronounced PAY-low-PEP-PA) Train is a mobile medical unit that annually travels through 36 South African rural areas five days a week providing medical, dental and eye care, health education, psychological counseling and training programs on HIV/AIDS to disadvantaged people in these areas. In rural provinces of South Africa, there is one doctor for every 5,000 people.

The Phelophepa represents social healing and reconciliation for what was a racially torn nation. Partly funded by the Transnet Foundation of South Africa, the program has been so successful that the South African Government will be launching a second train, Phelophepa II, in 2008.

For the past six years the American Friends of the Phelophepa Train have presented a gala dinner to celebrate and support the Train's travels throughout South Africa. US-based global business and social leaders, who share the goals and have made significant contributions, are recognized, not only for support of the cause but also for their efforts to improve the economic conditions in South Africa and the lives of its people.

For more information, please go to

http://www.americanfriendsofphelophepa.org.

About Deloitte

As used in this document, "Deloitte" means Deloitte & Touche USA LLP. Please see http://www.deloitte.com/about for a detailed description of the legal structure of Deloitte & Touche USA LLP and its subsidiaries.


'/>"/>
SOURCE Deloitte
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Deloitte Leadership Offers Crucial Convergence Considerations for Life Sciences Companies
2. CardioDynamics Ranked in Deloittes Technology Fast 50 Program for San Diego
3. WuXi PharmaTech (NYSE: WX) Wins Both Deloitte Technology Fast 50 China and Deloitte Technology Fast 500 Asia
4. WuXi PharmaTech (NYSE: WX) Ranked the 28th of Deloitte Technology Fast 50 China
5. Align Technology, Inc. Ranked 23rd in Deloittes Technology Fast 50 Program for Silicon Valley Scientific & Medical Equipment, and Bio-Technology Companies
6. Alma Lasers Ranked 9th in Deloitte Technology Fast 50 Award
7. Chairman & CEO of KIWA, Li Wei, Interviewed by Phoenix Satellite TV
8. Agendia BV Appoints Mr. Hessel Lindenbergh as Chairman of its Supervisory Board
9. OmniSonics Appoints J. Daniel Cole Chairman of the Board
10. Yves Lionel Assant is New Chairman of Gerresheimers Supervisory Board
11. Jeffrey H. Buchalter Joins MacroGenics Board of Directors as Chairman
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... 2016 , ... In anticipation of AxioMed’s exclusive cleanroom manufacturing ... President, Jake Lubinski will be traveling to Germany on December 6th. Mr. Lubinski ... Karlsruhe to discuss the benefits of a viscoelastic total disc replacement. , AxioMed ...
(Date:12/5/2016)... Dec. 5, 2016  Eisai Inc. announced today ... study of rufinamide, which were presented at the ... (AES) held from December 2-6 in ... safety, tolerability and cognitive data showed that patients ... safety and tolerability profiles, cognitive development and behavior, ...
(Date:12/4/2016)... 2016  In five studies being presented today during ... and Exposition in San Diego , ... the delivery of life-saving treatments to patients with a ... to carry therapies directly to the sites in the ... a substantial advantage over traditional, systemic methods. The studies ...
(Date:12/2/2016)... THOUSAND OAKS, Calif. , Dec. 2, 2016 ... AGN ) today announced the submission of a ... for ABP 215, a biosimilar candidate to Avastin ® ... biosimilar application submitted to the EMA. "The ... milestone as Amgen seeks to expand our oncology portfolio," said ...
Breaking Biology Technology:
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, Inc. ... therapeutics focused on the gut microbiome, today announced ... 25,000,000 shares of its common stock and warrants ... at a price to the public of $1.00 ... Synthetic Biologics from the offering, excluding the proceeds, ...
(Date:11/14/2016)... Calif. , Nov. 14, 2016 /PRNewswire/ ... biometric identification market, Frost & Sullivan recognizes ... & Sullivan Award for Visionary Innovation Leadership. ... in the biometric identification market by pioneering ... verification solution for instant, seamless, and non-invasive ...
(Date:6/22/2016)... LOS ANGELES , June 22, 2016 ... of identity management and verification solutions, has ... cutting edge software solutions for Visitor Management, ... ® provides products that add functional ... The partnership provides corporations and venues with ...
Breaking Biology News(10 mins):